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Abstract
Nondippers (people whose sleep systolic blood pressure (SBP) fails to decrease >10% from
daytime SBP) have increased risk of cardiovascular disease. The prevalence of nondipping in
younger adults has not been well-studied, nor has its value for predicting hypertension. We
examined the prevalence of nondipping in a sub-study of the Coronary Artery Risk Development
in Young Adults (CARDIA) Study. We used Cox regression to estimate the hazard ratio (HR)
conferred by nondipping for incident prehypertension or hypertension (preHTN/HTN) over 15
years. Of the 264 non-hypertensive participants at baseline, 118 (45%) were nondippers. Blacks
were more likely than Whites to be nondippers (52% vs 33%, p=0.004). The incidence rate of
preHTN/HTN was 29.2/1000 person-years among dippers and 36.2/1000 person-years among
nondippers. Compared to those in the lowest quartile of nighttime to daytime SBP, those in the
highest quartile were more likely to develop preHTN/HTN (HR 1.61; p =0.06), but this
relationship was attenuated after adjustment (HR 1.34; p =0.27). Our results demonstrate that
nondipping is common in young, nonhypertensive adults, and is more common in Blacks than
Whites. Nondipping might predate a meaningful clinically detected increase in BP in some people,
but more research in larger study samples is needed.
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Over the last two decades, through the use of 24-hour ambulatory blood pressure
monitoring, the importance of the diurnal blood pressure (BP) pattern has been more clearly
elucidated.1-7 Normally during sleep, BP decreases (“dips”) more than 10% from daytime
baseline BP. Individuals who do not exhibit this >10% decrease have been referred to as
nondippers. In patients with hypertension, nondipping has been shown to be associated with
target organ damage and cardiovascular events.1-6 In the general population, nondipping
may be a risk factor for cardiovascular disease mortality independent of the overall BP
during a 24-hour period.6 In one study of normotensive individuals (defined as clinic BP
<140/90 mm Hg and 24-hour ambulatory BP average <125/80 mm Hg), the nondipping
pattern was shown to be associated with cardiac hypertrophy and remodeling.7
Not only does the nondipping pattern appear to be associated with an increased
cardiovascular risk, but it is also common. Nondipping was recently shown to be present in
approximately 40% of untreated hypertensives and more than 50% of treated hypertensives.8
The nondipping pattern also occurs in approximately 30% of older normotensive adults.7
However, the prevalence of the nondipping pattern in younger adults who are not
hypertensive has not been well studied. Also not known is whether nondipping in young
normotensive adults is predictive of future hypertension.
In physiological terms, the sympathetic nervous system plays an important role in the
pathogenesis of hypertension and of cardiovascular disease.9 Autonomic imbalances
(increased sympathetic tone and decreased parasympathetic tone) lead to increased heart
rate, vasoconstriction, and increased BP. Elevated BP, in turn, leads to an alteration in
arterial and aortic baroreceptor function, and loss of sympathetic inhibition is one of the
mechanisms responsible for failure of BP to dip during sleep.10 It is possible that
nondipping is an early change in a person’s BP pattern, and the loss of nocturnal BP
reduction may predate the onset of clinical hypertension.
The objectives of this study were (1) to estimate the prevalence of the nondipping BP pattern
among young, non-hypertensive Black and White adults, and (2) to examine whether a
nondipping BP pattern among young adults is associated with the development of
prehypertension or hypertension. We hypothesized that young adults with a nondipping




The Coronary Artery Risk Development in Young Adults Study (CARDIA) is an ongoing,
prospective, epidemiologic study, conducted at four sites throughout the United States. A
detailed description of the study design and recruitment methods can be found in an earlier
publication.11 The data presented in this paper are from a subgroup of individuals who
participated in an ambulatory BP monitoring substudy in 1990 (year 5 of CARDIA) and had
ongoing follow-up visits. The CARDIA study and this substudy were approved by the
appropriate Institutional Review Boards (IRBs), and informed consent was obtained from
each study participant. The plans for this secondary analysis were also submitted to the
University of North Carolina’s Office of Human Research Ethics and deemed exempt from
further review.
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As previously described,12 for feasibility reasons, ambulatory BP monitoring measurements
were performed at only one of the CARDIA study sites (Birmingham, AL). A list of 100
people randomly chosen from each of the four race/gender subgroups (Black and White men
and women) was generated at the CARDIA Coordinating Center. After excluding
individuals whose jobs would make ambulatory BP monitoring difficult (e.g., truck drivers,
delivery people), a total of 316 people (147 men and 169 women; 112 Whites and 204
Blacks) participated in the ambulatory BP monitoring sub-study.
Ambulatory Blood Pressure Monitoring
Ambulatory blood pressure was monitored over a 24 hour period using a Suntech
Accutracker II (Suntech Medical, Morrisville, NC), using an appropriately sized cuff which
was inflated approximately every 20 minutes.13 To reduce anticipation effects, the inflation
schedule was variable. If any value outside preset limits (systolic ≥220 or ≤80 mm Hg;
diastolic ≥130 or ≤40 mm Hg) was detected during a recording, that measurement was
rejected and another measurement was immediately made. In addition, a change of 50 mm
Hg in systolic pressure, of 40 mm Hg in diastolic pressure, or of 50 mm Hg in pulse pressure
also triggered a rejection and a new reading. Daytime was defined as the period between
0700 and 2359, and we required a minimum of 14 adequate measurements. Nighttime was
defined as the period between 0000 and 0659, and we required a minimum of six adequate
measurements. Blood pressure dipping at baseline was quantified as the ratio of mean
nighttime systolic BP to mean daytime systolic BP. Nondipping pattern was defined as a
ratio ≥0.90.
Clinic Blood Pressure Measurements
Prior to study visits, participants were asked to refrain from smoking and heavy physical
activity. At each visit, after five minutes of rest, three seated right arm BP measurements
were recorded at one-minute intervals. Using an appropriately sized cuff, the first-phase and
fifth-phase Korotkoff sounds were taken as the systolic and diastolic blood pressures,
respectively, using a random zero sphygmomanometer. Individuals with hypertension at
baseline (defined as on BP-lowering meds at CARDIA year 5) or CARDIA visit 5 clinic BP
average (based on second and third readings) of either systolic ≥140 mm Hg or diastolic
≥90 mm Hg were excluded from this analysis, leaving 264 “at-risk” people in the final study
sample. At the 15-year follow-up visit (CARDIA year 20), clinic BP was measured using a
digital oscillometric monitor (Omron HEM-907XL; Online Fitness, Santa Monica,
California) rather than a random zero sphygmomanometer. A calibration study was
performed at year 20 in approximately 900 participants, and we used the formulae calibrated
year 20 systolic blood pressure =3.74+0.96 * observed Omron systolic blood pressure and
calibrated year 20 diastolic blood pressure =1.30+0.97 * observed Omron systolic blood
pressure.
Covariates
Education was determined by self report of highest grade level achieved. Body mass index
(BMI) was calculated based on measured height and weight at the baseline visit. Diabetes
mellitus was defined as a fasting glucose level ≥126 mg/dL or use of hypoglycemic agents
at baseline (CARDIA year 5). Family history of hypertension and smoking status were
determined by self-report. Alcohol consumption was a continuous variable (ethanol intake,
mL/day). Physical activity was assessed by the CARDIA physical activity questionnaire,
which measured the self-reported frequency of participation in 13 different categories of
recreational sports and exercise in the past 12 months.14 Physical activity scores were
computed by multiplying the frequency of participation by the intensity of activity and
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reported as “exercise units.” Energy expenditure could not be computed because duration of
activity was not queried.
Analysis
Our exposure variable was nondipping pattern based on ambulatory BP monitoring
performed in 1990. Our outcome was clinical worsening of BP category—from optimal BP
to incident prehypertension or hypertension, or from prehypertension to incident
hypertension. Hypertension was defined as a clinic visit average (of second and third
readings) systolic BP ≥ 140 mmHg or average diastolic BP ≥ 90 mmHg or interval initiation
of an antihypertensive medication. Prehypertension was defined as a clinic visit BP average
(of second and third readings) systolic BP ≥ 120 mm Hg or average diastolic BP ≥ 80 mm
Hg with neither reading ≥140/90 mm Hg. Time of follow-up was 15 years. In the survival
analyses, a participant was censored when a change in BP category was detected (optimal
BP, defined as systolic BP < 120 mm Hg and diastolic BP < 80 mm Hg, to prehypertension,
prehypertension to hypertension, or optimal BP to hypertension). A categorization change
from optimal BP to hypertension was counted as a change from optimal to hypertension
whether or not the person had BP in the prehypertension range in the interim.
We calculated the crude hazard ratio and then performed a series of Cox regression analyses.
In the first model, we adjusted only for race. In a second model, we adjusted for race and
BMI. In a fully adjusted model, we included baseline clinic systolic BP as well as age, sex,
race/ethnicity, BMI, diabetes mellitus, physical activity, family history of hypertension,
alcohol consumption, and cigarette smoking.15 We also tested the significance of an
interaction term of race and dipping status. We repeated the regression analyses using the




The mean age of participants at baseline was 30 years (Table 1). Forty five percent of
participants were male, and 63% were Black. Few had known diabetes, but half were
overweight or obese. Among this study sample, 28% were current smokers at baseline.
Overall, there were 118 people (45%) with a nondipping BP pattern. This percentage
included 11 people whose BP was actually higher at night—so-called “reverse dippers”. A
total of 201 participants had optimal clinic BP at baseline. The remaining 63 participants had
baseline clinic BP in the prehypertension range. Among those with optimal BP, 45% were
nondippers, and among those with prehypertension, 44% were nondippers. Mean clinic BP
among dippers and nondippers was similar at baseline, as was mean 24 hour average BP
(Table 2). As expected, the mean nighttime BP was lower among the dippers (102/57 mm
Hg vs 109/62 mm Hg). The associated BP changes from day to night reflect these
differences. Interestingly, daytime BP average was slightly lower among nondippers (115/69
mm Hg vs 118/70 mm Hg).
Associations with Nondipping Status
Of all characteristics examined, Black race and obesity were the only factors associated with
nondipping status (Table 3). Among White participants, 33% were nondippers/reverse
dippers, while among Blacks, 52% were nondippers/reverse dippers (p=0.004). Among
normal weight or overweight participants, 41% in each category were nondippers/reverse
dippers, but among obese participants, 57% were nondippers/reverse dippers (p=0.07).
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Incident Change in BP Category
Over the 15 years of follow-up, there were 128 incident cases of clinical worsening of BP
category (81 incident cases of hypertension and 47 incident cases of prehypertension) (Table
4). The incidence rate of change in clinical BP category was 29.2 per 1000 person-years
among the dippers and 36.2 per 1000 person-years among the nondippers/reverse dippers for
a hazard ratio of 1.33 (p=0.10). When adjusted for race, the association was mitigated (HR
1.22; p=0.27). Additional adjustment for BMI further reduced the hazard ratio, but full
adjustment with all covariates had little effect. The interaction of race and dipping status was
not significant (p=0.37).
The ratio of baseline nighttime to daytime systolic BP ratio ranged from 0.736 to 1.19.
Compared to those in the lowest quartile of nighttime to daytime systolic BP, those in the
highest quartile had a hazard ratio of 1.61 (p=0.06) for change in clinical BP category (Table
5). When adjusted for race, the association persisted in the hypothesized direction, but the
magnitude of the association was reduced, and the near-statistical significance of highest to
lowest quartile was mitigated (HR 1.43; p=0.17). Further adjustment for BMI also mitigated
the association. A fully adjusted model differed little from the model adjusted only for race
and BMI. In a Cox regression model examining baseline nighttime to daytime systolic BP
ratio as a continuous variable, an increase of 0.05 in the ratio was associated with a 5%
increase (fully adjusted for covariates) in change in clinical BP category, but this was not
significant (HR 1.05; p=0.48).
Discussion
Among a sample of young adults with non-hypertensive blood pressure at baseline, we
found that the nondipping pattern was common, present in 33% of Whites and 52% of
Blacks. We also found that over a follow-up period of 15 years, nocturnal BP dipping status
was positively, but not significantly (after adjustment) predictive of incident prehypertension
or hypertension. The first implication of our findings is that many young otherwise healthy
adults, though not hypertensive, may have a diurnal pattern of BP that places them at
increased risk of target organ damage and increased cardiovascular disease mortality. The
second implication is that nondipping in younger adults might predate hypertension,
suggesting an early (pre-clinical) autonomic imbalance as a contributor. However, this
finding needs confirmation in larger studies.
Since older age has repeatedly been a factor associated with the nondipping status,6,8 we
were somewhat surprised to find a high prevalence of the nondipping status in these young
adults with non-hypertensive blood pressure. Previous studies have examined the prevalence
of the nondipping pattern in various subgroups. Most such studies have been either in older
people or in people with known hypertension. For example, one study of 183 unmedicated
hypertensive patients showed the nondipping pattern to be present in 43% [16]. In a large
international database containing ambulatory BP data on 7458 adults (mean age 57 years),
nearly half of whom were taking BP-lowering drugs, 29% of participants were nondippers/
reverse dippers.17 In a small study of older, normotensive Japanese adults, 34% were
nondippers.7 A similar percentage (36%) was seen in a study of 1542 adults with a mean
age of 61 years and representative of the general population of older adults in Japan.6 In
more a recent cross-sectional study of 8383 untreated and 34,563 treated hypertensives, the
nondipping pattern was present in 41% and 53%, respectively.8 In the HARVEST study,
among never-treated borderline to mild young hypertensives (n=1062), nocturnal BP
nondipping was present in 31%.18 One study of a British population published in 1998
found that among 265 healthy, normotensive volunteers who underwent office and
ambulatory BP measurements, 17% were nondippers.19 Compared to the participants in our
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study, those in the British study were slightly older with a mean age of 39 years. Most
importantly, however, all of the participants in that study were White.
In our study, Black race was the one factor significantly associated with nondipping status.
Similar findings have been reported previously.20,21 In a study of 171 somewhat older
(mean age of 53 years) Black and White normotensive and mildly hypertensive adults, 54%
of Blacks and 39% of Whites were nondippers.20 The observation of greater likelihood of
nondipping among Blacks, even at earlier ages as shown in our study, is important and may
partially explain the greater severity of hypertension-related target organ damage and
resultant cardiovascular and renal disease in Blacks compared to Whites.22,23
We hypothesized that young non-hypertensive adults with a nondipping pattern would be
more likely to develop a change in their clinical BP category, and our findings are
suggestive that this is the case. Although two-side p-values were not significant, the findings
are in the hypothesized direction, and one-sided p-values would have reached statistical
significance in the crude analyses. These interesting results should therefore not be readily
dismissed as due to chance, and further studies are warranted. There are few other studies to
date that have examined this possibility. In the HARVEST study, mentioned above,
nocturnal BP nondipping was a strong predictor of sustained clinic hypertension after a
mean of 68 months of follow-up.18 An important difference from our study was that the
participants in the HARVEST study already had elevated clinic BP at baseline, and many
began antihypertensive treatment over the course of follow-up.
In making the case of the potential clinical significance of our findings, we have assumed
that the definition and prognosis of the nondipping pattern is the same in young, healthy,
normotensive adults as in middle-aged, older, and/or hypertensive adults. An alternative
assessment of our findings is that people who have optimal or near-optimal daytime BP do
not exhibit a 10% nocturnal dip. In other words, it may be “normal” for people with optimal
(or “low”) daytime BP not to dip as much at night. Our interesting finding that average
daytime BP among nondippers was actually lower than that of dippers while 24-hour
averages were very similar between the two groups further supports this additional new
hypothesis. One study previously demonstrated that even in normotensive individuals, the
adjusted risk of cardiovascular mortality among nondippers is over twice that of dippers.6
However, average daytime BP in that study sample was 124/73 mm Hg compared to the
average of 117/70 mm Hg in this study.
While our study had a reasonably long follow-up period over which to detect changes in
clinical BP status, it was limited by a relatively small sample size and therefore may have
been underpowered to detect a significant difference in prehypertension and hypertension
rates. We must also acknowledge the possibility of misclassification bias in the
measurement of nondipping status. Classifying patients into dippers or nondippers based on
one ambulatory BP monitoring may be misleading and related to the quality of sleep the
person experiences during the session.24 However, if misclassification bias did occur in this
study, it would be nondifferential and cause the magnitude of association we found to
actually be smaller than the true association. One study that used three ambulatory BP
monitoring sessions to classify participants found that while associations with dipping status
based on the initial session were somewhat weaker than associations based on all three, the
patterns were similar.20
Conclusions
The nondipping BP pattern is common in young adults with normal BP (prehypertension as
well as optimal BP). This finding has clinical significance because research to date has
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shown that nondipping is associated with cardiovascular target organ damage and mortality
independent of elevated BP. Blacks, even at younger ages and when normotensive, have a
higher prevalence than Whites of nondipping, a finding that may partially explain their
greater hypertension-related morbidity. Nondipping might predate clinical hypertension in
some people, but further studies with larger sample sizes are needed to clarify this
hypothesis. More importantly, if it is shown in future studies that reduction of nocturnal BP
in nondippers delays hypertension onset or leads to reduced target organ damage and
cardiovascular disease events, more routine use of 24-hour ambulatory BP monitoring for
screening would need to be considered.
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Table 1
Characteristics of Sample at Baseline (CARDIA Year 5) (N=264)
Age, mean (SD), y 30.0 (3.7)
Age categories, %
 23-29 y 45.5





Education, mean (SD), y 14.0 (2.1)
BMI, mean (SD) 26.3 (5.2)
BMI categories, %
 Normal (<25 kg/m2) 44.7
 Overweight (25-29 kg/m2) 30.7
 Obese (≥ 30 kg/m2) 24.6
Known diabetes, % 2.0
Family history of hypertension, % 58.3
Smoker, %
 Never smoker 62.5
 Former smoker 9.5
 Current smoker 28.0
Alcohol consumption, mL/day mean (SD) 11.2 (22.9)
Physical activity, Kcal/Day, mean (SD) 320.0 (266.9)
BMI, body mass index
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Table 2






 Characteristic Mean±SD Mean±SD
Clinic BP
 SBP 108.0 (8.7) 106.9 (9.6) 0.31
 DBP 71.6 (9.0) 71.8 (8.2) 0.83
Ambulatory BP
 24-h average SBP 114.6 (9.2) 113.9 (8.9) 0.59
 24-h average DBP 67.3 (6.2) 67.1 (5.7) 0.77
 Average daytime SBP 118.3 (9.6) 115.2 (8.9) 0.008
 Average daytime DBP 70.4 (6.7) 68.7 (5.8) 0.03
 Average nighttime SBP 101.7 (8.7) 109.3 (10.1) <0.0001
 Average nighttime DBP 56.8 (6.1) 62.0 (7.3) <0.0001
Change in SBP, day - night 16.6 (3.9) 5.9 (5.1) <0.0001
Change in DBP, day - night 13.6 (4.6) 6.7 (5.6) <0.0001
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Table 3
Characteristics Associated with Nondipping Status in Young Adults (CARDIA Year 5)
n/N Percent Mean (SD) p-value
Age categories 0.51
 2329 y 51/120 42.5
 3036 y 67/144 46.5
Sex 0.65
 Male 55/119 46.2
 Female 63/145 43.5
Race 0.004
 White 32/97 33.0
 Black 86/167 51.5
Education level 0.89
 < High school 5/12 41.7
 High school graduate 37/79 46.8
 At least some college 76/173 43.9
BMI categories 0.07
 Normal (<25 kg/m2) 48/118 40.7
 Overweight (25-29 kg/m2) 33/81 40.7
 Obese (≥ 30 kg/m2) 37/65 56.9
Known diabetes 0.49
 Yes 3/5 60.0
 No 115/259 44.4
Family history of hypertension 0.97
 Yes 69/154 44.8
 No 49/110 44.6
Smoker 0.22
 Never smoker 69/165 41.8
 Former/current smoker 49/99 49.5
Alcohol consumption, mL/day 0.65
 Nondippers (n=118) - - 11.9 (23.9)
 Dippers (n=146) - - 10.6 (22.0)
Physical activity, Kcal/day 0.82
 Nondippers (n=118) - - 316.0 (241.0)
 Dippers (n=146) - - 323.3 (286.9)
BMI, body mass index; Dipper = mean nighttime:mean daytime systolic BP ratio of <0.90;Nondipper = mean nighttime:mean daytime systolic BP
ratio ≥0.90
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Table 4





No. of cases/Total 64/146 64/118
Rate (No. per 1000 person-years) 29.2 36.2
HR (95% CI) 1.0 1.33 0.10
Race-adjusted
HR (95% CI) 1.0 1.22 0.27
Adjusted for race and BMI
HR ((95% CI) 1.0 1.13 0.50
Fully adjusted **
HR (95% CI) 1.0 1.15 0.45
HR, hazard ratio
Incident prehypertension was defined as clinic BP ≥120/80 mm Hg. Incident hypertension was defined as clinic BP ≥140/90 mm Hg or taking
antihypertensive medication at any of CARDIA years 7, 10, 15 or 20. Those taking BP meds or with a BP ≥140/90 mm Hg at CARDIA year 5
(CARDIA Year 5 is baseline for this analysis) were excluded. An “event” occurred if a change in BP category was detected (optimal BP to
prehypertension, prehypertension to hypertension, or optimal BP to hypertension).
**
Adjusted for age, sex, race, baseline clinic systolic BP, BMI, diabetes, family history of hypertension, smoking, alcohol intake, an physical
activity
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Table 5




























HR, hazard ratio; ref, referent
An “event” occurred if a change in BP category was detected (optimal BP to prehypertension, prehypertension to hypertension, or optimal BP to
hypertension).
Quartiles of mean nocturnal systolic BP/mean diurnal systolic BP ratio: Q1: 0.7360-0.8621 (n=66); Q2: 0.8624-0.8926 (n=66); Q3: 0.8934-0.9385
(n=66); Q4: 0.9388-1.1855 (n=66)
*
P for trend based on continuous ratio variable
**
Adjusted for age, sex, race, BMI, diabetes, family history of hypertension, smoking, alcohol intake, physical activity, and baseline clinic systolic
BP
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